{
    "clinical_study": {
        "@rank": "126068", 
        "arm_group": [
            {
                "arm_group_label": "Acupuncture & NCPB", 
                "arm_group_type": "Experimental", 
                "description": "The NCPB will be administered once at the start of the trial and the acupuncture will be performed 3 times per week for 2 weeks (6 times in total)."
            }, 
            {
                "arm_group_label": "NCPB", 
                "arm_group_type": "Active Comparator", 
                "description": "The NCPB alone will be applied to the patients in this group, once at the start of the trial."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to investigate the effectiveness of acupuncture for alleviating the upper\n      abdominal pain of cancer patients"
        }, 
        "brief_title": "Efficacy Study of Acupuncture to Treat the Upper Abdominal Pain of Cancer Patients", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Abdominal Pain", 
        "condition_browse": {
            "mesh_term": "Abdominal Pain"
        }, 
        "detailed_description": {
            "textblock": "Neurolytic celiac plexus block (NCPB) is a commonly performed procedure in patients with\n      intractable pain due to malignancies involving the upper and mid abdomen. Recently,\n      acupuncture is used as one of alternative interventions to treat cancer-related pains. This\n      pilot study aims to investigate the effectiveness of pain-relief of acupuncture via\n      comparing acupuncture plus NCPB with NCPB alone. Total 14 cancer patients with NCPB will be\n      randomized into two groups of acupuncture and control."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age over 18 years\n\n          -  Upper abdominal pain VAS \u2265 5\n\n          -  Unresectable abdominal malignancy, moderate or severe abdominal pain poorly\n             controlled with pharmacotherapy.\n\n          -  All patients had advanced cancer diagnosed by histological/cytological examination\n\n          -  Follow-up possible during the clinical trial\n\n          -  Written informed consent voluntarily\n\n        Exclusion Criteria:\n\n          -  Patient with uncorrectable coagulopathy\n\n          -  Patient with allergy to local anesthesics or alcohol..\n\n          -  Previous NCPB or had implanted epidural or intrathecal analgesic therapy\n\n          -  Inability to lie prone\n\n          -  Disease encasing the celiac plexus on computed Tomography scan\n\n          -  Patients with psychiatric diseases that could have affected the study assessments\n\n          -  Significant renal or hepatic disease\n\n          -  Inability to comprehend or express oneself in the Korean language\n\n          -  Refusal to participate in the trial or to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913574", 
            "org_study_id": "CIMI-13-01-09"
        }, 
        "intervention": [
            {
                "arm_group_label": "Acupuncture & NCPB", 
                "description": "Acupuncture is applied three times a week for 20 minutes for 2 weeks (total 6 sessions). 9 Acupuncture points, CV12, CV13, P6, SP4, ST36(bilateral),LI4 (bilateral), LR3 (bilateral), ST34 (bilateral), and GB21(bilateral) are used, and CV12, CV13, ST36, and LR3 are electro-stimulated.", 
                "intervention_name": "Acupuncture", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Acupuncture & NCPB", 
                    "NCPB"
                ], 
                "description": "An anaesthetic test is performed injecting 2ml mepivacaine. After assessing the efficacy and safety of this test, 10 ml of absolute alcohol is injected via each needle.", 
                "intervention_name": "Neurolytic celiac plexus block (NCPB)", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Daegu", 
                    "country": "Korea, Republic of", 
                    "state": "Kyungsangbukdo"
                }, 
                "name": "Daegu Catholic University Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study of Acupuncture to Alleviate the Upper Abdominal Pain of Cancer Patients Treated With Neurolytic Celiac Plexus Block", 
        "overall_contact": {
            "email": "jychung@cu.ac.kr", 
            "last_name": "Jin-Young Chung, M.D,Ph.D.", 
            "phone": "+82 53 650 4505"
        }, 
        "overall_official": [
            {
                "affiliation": "Comprehensive and Integrative Medicine Institute", 
                "last_name": "Jeong-Chul Seo, KMD, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Daegu Oriental Hospital of Daegu Haany University", 
                "last_name": "Min-Ah Gwak, KMD, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Comprehensive and Integrative Medicine Institute", 
                "last_name": "Seong_Hoon Park, KMD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The patients will be required to document 100mm pain VAS, where '0' represents 'no pain' and '100', 'unbearable pain'. The change of pain will be reported by comparing the mean VAS before treatment, after 1 week, after 2 week, and 1 week follow-up.", 
            "measure": "Visual analogue scale(VAS)", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913574"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Daegu Catholic University Medical Center", 
            "investigator_full_name": "Jin-Young, Chung", 
            "investigator_title": "Department of anesthesiolgy", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Drug consumption per day will be documented before treatment, after 1 week, after 2 week, and 1 week follow-up.", 
            "measure": "Analgesic drug consumption", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 2 weeks"
        }, 
        "source": "Daegu Catholic University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Daegu Catholic University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}